Sagimet Biosciences Inc Series A Common Stock
Price & Volume
Stats
See more52W Range | $1.73-$11.41 |
Market Cap | $238.7M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 12 days ago
Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis
Yahoo Finance • 19 days ago
Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit
Yahoo Finance • last month
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
Yahoo Finance • 2 months ago
Sagimet Biosciences GAAP EPS of -$0.32 beats by $0.21
About
CEO | Mr. David A. Happel |
CFO | Mr. Thierry Chauche |
Address | 155 Bovet Road, San Mateo, CA, United States, 94402 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
